Get started
Author

Dingshan Deng

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study
2022 · Jiao Hu, Jinbo Chen, et al. · Cell Reports Medicine · 129
PDF
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
2023 · Zhiyong Cai, Jinbo Chen, et al. · Advanced Science · 70
PDF
S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8+ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
2023 · Huihuang Li, Jinbo Chen, et al. · Advanced Science · 49
PDF
Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48‐ADC) combined immunotherapy in patients with muscle‐invasive bladder cancer: A multi‐center real‐world study
2025 · Jiao Hu, Luzhe Yan, et al. · iMeta · 34
PDF
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8 + T cell infiltration and functional transition
2023 · Anze Yu, Jiao Hu, et al. · Journal for ImmunoTherapy of Cancer · 27
PDF
An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
2022 · Zicheng Xiao, Zhiyong Cai, et al. · Frontiers in Immunology · 16
An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts
2023 · Hao Deng, Dingshan Deng, et al. · Frontiers in Genetics · 12
Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma
2022 · Dingshan Deng, Fenglian Liu, et al. · Frontiers in Immunology · 9
Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
2023 · Chunyu Zhang, Jiatong Xiao, et al. · Frontiers in Pharmacology · 8
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance
2025 · Zhi Liu, Chunyu Zhang, et al. · Theranostics · 7
PDF
A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts
2023 · Dingshan Deng, Xiaowen Li, et al. · Frontiers in Pharmacology · 6
Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer
2024 · Dingshan Deng, Jiatong Xiao, et al. · Journal of Hematology & Oncology · 5
PDF
Neoadjuvant immunotherapy driven bladder preservation for muscle invasive bladder cancer
2025 · Jiao Hu, Luzhe Yan, et al. · iMeta · 4
PDF
Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
2025 · Luzhe Yan, Haisu Liang, et al. · BMC Cancer · 4
ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts
2023 · Jinhui Liu, Chunliang Cheng, et al. · Frontiers in Genetics · 4
PDF
A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
2022 · Huihuang Li, Jiao Hu, et al. · Frontiers in Genetics · 4
The ZNF737-CXCL10 axis drives immune exclusion and resistance to anti-PD-1 therapy in bladder cancer
2026 · Xin Gao, Jinhui Liu, et al. · International Immunopharmacology · 3
Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer
2024 · Zhenyu Nie, Bolong Liu, et al. · Biomarker Research · 3
PDF
Microsurgical varicocelectomy and revascularization: a novel approach to varicocele treatment
2025 · Jinhui Liu, Dingshan Deng, et al. · Current Problems in Surgery · 2
SWI/SNF-associated molecular subtypes reshape tumor microenvironmental features and inform precision therapeutic strategies in bladder cancer
2026 · Tiezheng Qi, Wenqi Yang, et al. · Frontiers in Cellular and Infection Microbiology · 1
ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts
2023 · Zhiwei Li, Yiyan Yao, et al. · Frontiers in Pharmacology · 1
Re: Nicolaus F. Debatin, Elena Bady, Tim Mandelkow, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024;86:42–51
2024 · Tiezheng Qi, Benyi Fan, et al. · European Urology
Works count: 25
Citation count: 398
H-index: 8
I10-index: 7
Year
Topic
Type